459 related articles for article (PubMed ID: 28827386)
1. Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.
Suvas S
J Immunol; 2017 Sep; 199(5):1543-1552. PubMed ID: 28827386
[TBL] [Abstract][Full Text] [Related]
2. Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor.
Yang L; Di G; Qi X; Qu M; Wang Y; Duan H; Danielson P; Xie L; Zhou Q
Diabetes; 2014 Dec; 63(12):4262-74. PubMed ID: 25008176
[TBL] [Abstract][Full Text] [Related]
3. Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders.
Singh RB; Naderi A; Cho W; Ortiz G; Musayeva A; Dohlman TH; Chen Y; Ferrari G; Dana R
Ocul Surf; 2022 Jul; 25():142-153. PubMed ID: 35779793
[TBL] [Abstract][Full Text] [Related]
4. Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.
Yanai R; Nishida T; Hatano M; Uchi SH; Yamada N; Kimura K
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):29. PubMed ID: 32697304
[TBL] [Abstract][Full Text] [Related]
5. Substance P and its Inhibition in Ocular Inflammation.
Bignami F; Rama P; Ferrari G
Curr Drug Targets; 2016; 17(11):1265-74. PubMed ID: 26477461
[TBL] [Abstract][Full Text] [Related]
6. Role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing.
Kowtharapu BS; Murín R; Jünemann AGM; Stachs O
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401709
[TBL] [Abstract][Full Text] [Related]
7. Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling.
Liu L; Dana R; Yin J
FASEB J; 2020 May; 34(5):6229-6243. PubMed ID: 32162744
[TBL] [Abstract][Full Text] [Related]
8. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.
Leal EC; Carvalho E; Tellechea A; Kafanas A; Tecilazich F; Kearney C; Kuchibhotla S; Auster ME; Kokkotou E; Mooney DJ; LoGerfo FW; Pradhan-Nabzdyk L; Veves A
Am J Pathol; 2015 Jun; 185(6):1638-48. PubMed ID: 25871534
[TBL] [Abstract][Full Text] [Related]
9. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
10. Endogenous substance P in corneal epithelial cells and keratocytes.
Watanabe M; Nakayasu K; Iwatsu M; Kanai A
Jpn J Ophthalmol; 2002; 46(6):616-20. PubMed ID: 12543186
[TBL] [Abstract][Full Text] [Related]
11. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Organ Injury the Role of Substance P and Its Receptors.
Zhu Z; Bhatia M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047113
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
Muñoz M; Muñoz MF; Ayala A
J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
[TBL] [Abstract][Full Text] [Related]
15. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1.
Nakamura M; Ofuji K; Chikama T; Nishida T
Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288
[TBL] [Abstract][Full Text] [Related]
16. [Substance P and human skin].
Staniek V; Misery L
Pathol Biol (Paris); 1996 Dec; 44(10):860-6. PubMed ID: 9157365
[TBL] [Abstract][Full Text] [Related]
17. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.
Zhan M; Zheng W; Jiang Q; Zhao Z; Wang Z; Wang J; Zhang H; He S
Cell Biol Toxicol; 2017 Aug; 33(4):389-405. PubMed ID: 28154998
[TBL] [Abstract][Full Text] [Related]
19. Substance P receptor mediated maintenance of chronic inflammation in EAE.
Reinke EK; Johnson MJ; Ling C; Karman J; Lee J; Weinstock JV; Sandor M; Fabry Z
J Neuroimmunol; 2006 Nov; 180(1-2):117-25. PubMed ID: 16942803
[TBL] [Abstract][Full Text] [Related]
20. The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy.
Kokabi F; Ebrahimi S; Mirzavi F; Ghiasi Nooghabi N; Hashemi SF; Hashemy SI
Biofactors; 2023; 49(3):534-559. PubMed ID: 36651605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
